CluePoints, a provider of statistical and AI-driven software solutions, and the FDA have extended their long-standing collaboration.   Under the original CRADA between FDA and CluePoints, software was developed and CluePoints’ existing software was enhanced to produce a ranked list of anomalous sites to help prioritize site inspection(s) for FDA inspectors.   As a result of the original CRADA, the CluePoints software was deployed in the FDA high performance computing environment, new statist...